Next-generation sequencing (NGS) technology has revolutionized the life science and human health industries. Top-Down Analytics estimates that the total NGS market will reach $6.5 billion by 2021 from just under $3 billion in 2015. Sales of compact systems are expected to grow faster than those of large-scale platforms. Regionally, Asia and the Pacific Rim region will experience the fastest rate of market growth. Diagnostic and clinical research applications, with a focus on cancer biology, are a new wave of future growth for NGS.
The report also presents historical information dating back to 2009. Detailed data on installed base, unit shipments, competitive intelligence, and regional segmentation down to the individual country level make this report the most comprehensive market report on NGS available today.